Trial intelligence / Profile preview

Gabapentin for pediatric partial seizures

NCT00603473Phase 3Completed

Sponsor
Viatris
Start
Jan 2008
Primary completion
Dec 2009
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of gabapentin in focal seizures, sponsored by Viatris. Started Jan 2008; status: completed.

02

Drugs

gabapentin
03

Conditions

focal seizures

Beyond the preview

Go deeper on NCT00603473.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00603473.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call